# Inova Fairfax Hospital

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/inova-fairfax-hospital/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 77.2 |
| Citations | 505,103 |
| City | Falls Church |
| Country | US |
| Description | Inova Fairfax Hospital is a research organisation in Falls Church, US. OpenAlex records 6,477 works and 505,103 citations for it. 1,915 researchers list it as their most recent affiliation. |
| Homepage | http://www.inova.org/ifh |
| OpenAlex ID | https://openalex.org/I2800468613 |
| Region | Virginia |
| Researchers | 1,915 |
| ROR ID | https://ror.org/0212h5y77 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q6036707 |
| Works | 6,477 |

## University papers

Showing 12 of 19.

- [Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline](https://scholariq.org/papers/management-of-immune-related-adverse-events-in-patients-treated-with-immune/)
- [Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation](https://scholariq.org/papers/sotorasib-for-lung-cancers-with-i-kras-i-p-g12c-mutation/)
- [Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial](https://scholariq.org/papers/obeticholic-acid-for-the-treatment-of-non-alcoholic-steatohepatitis-interim/)
- [Adagrasib in Non–Small-Cell Lung Cancer Harboring a <i> KRAS <sup>G12C</sup> </i> Mutation](https://scholariq.org/papers/adagrasib-in-non-small-cell-lung-cancer-harboring-a-i-kras-sup-g12c-sup-i/)
- [Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer](https://scholariq.org/papers/brigatinib-versus-crizotinib-in-i-alk-i-positive-non-small-cell-lung-cancer/)
- [Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial](https://scholariq.org/papers/efficacy-and-safety-of-trabectedin-or-dacarbazine-for-metastatic-liposarcoma-or/)
- [First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic<i>EGFR</i>Mutations](https://scholariq.org/papers/first-line-gefitinib-in-patients-with-advanced-non-small-cell-lung-cancer/)
- [Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C](https://scholariq.org/papers/rates-and-risk-factors-of-liver-fibrosis-progression-in-patients-with-chronic/)
- [Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer](https://scholariq.org/papers/perioperative-durvalumab-for-resectable-non-small-cell-lung-cancer/)
- [Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study](https://scholariq.org/papers/amivantamab-in-egfr-exon-20-insertion-mutated-non-small-cell-lung-cancer/)
- [Alectinib in Crizotinib-Refractory <i>ALK-</i>Rearranged Non–Small-Cell Lung Cancer: A Phase II Global Study](https://scholariq.org/papers/alectinib-in-crizotinib-refractory-i-alk-i-rearranged-non-small-cell-lung-cancer/)
- [Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials](https://scholariq.org/papers/selonsertib-for-patients-with-bridging-fibrosis-or-compensated-cirrhosis-due-to/)

## University top topics

Showing 8 of 25.

- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Mechanical Circulatory Support Devices](https://scholariq.org/topics/mechanical-circulatory-support-devices/)
- [Pulmonary Hypertension Research and Treatments](https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/)
- [Transplantation: Methods and Outcomes](https://scholariq.org/topics/transplantation-methods-and-outcomes/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Cardiac Arrest and Resuscitation](https://scholariq.org/topics/cardiac-arrest-and-resuscitation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.